How does p21ras transform cells?

[1]  P. O’Connell,et al.  The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 , 1990, Cell.

[2]  M. Wigler,et al.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.

[3]  P. Warne,et al.  Stimulation of p21ras upon T-cell activation , 1990, Nature.

[4]  W. Kabsch,et al.  Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch molecules , 1990, Cell.

[5]  B. Brownstein,et al.  Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. , 1990, Science.

[6]  P. O'Connell,et al.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus , 1990, Cell.

[7]  A. Wittinghofer,et al.  Inhibition of GTPase activating protein stimulation of Ras-p21 GTPase by the Krev-1 gene product. , 1990, Science.

[8]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[9]  A. Brown,et al.  ras p21 and GAP inhibit coupling of muscarinic receptors to atrial K+ channels , 1990, Cell.

[10]  W. W. Nichols,et al.  Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene , 1990, Molecular and cellular biology.

[11]  H. Kung,et al.  Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C. , 1990, Science.

[12]  A. Fernandez,et al.  ras‐induced c‐fos expression and proliferation in living rat fibroblasts involves C‐kinase activation and the serum response element pathway. , 1990, The EMBO journal.

[13]  C. Marshall,et al.  Stimulation of phosphatidylcholine hydrolysis, diacylglycerol release, and arachidonic acid production by oncogenic ras is a consequence of protein kinase C activation. , 1989, The Journal of biological chemistry.

[14]  W. Kabsch,et al.  Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation , 1989, Nature.

[15]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[16]  Y. Ito,et al.  Loss of responsiveness of an AP1-related factor, PEBP1, to 12-O-tetradecanoylphorbol-13-acetate after transformation of NIH 3T3 cells by the Ha-ras oncogene , 1989, Journal of Virology.

[17]  H. Weintraub,et al.  Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1 , 1989, Cell.

[18]  A. Hall,et al.  p21H‐ras‐induced morphological transformation and increases in c‐myc expression are independent of functional protein kinase C. , 1989, The EMBO journal.

[19]  H. Kitayama,et al.  A ras-related gene with transformation suppressor activity , 1989, Cell.

[20]  Frank McCormick,et al.  ras GTPase activating protein: Signal transmitter and signal terminator , 1989, Cell.

[21]  I. Macara.  Elevated phosphocholine concentration in ras-transformed NIH 3T3 cells arises from increased choline kinase activity, not from phosphatidylcholine breakdown , 1989, Molecular and cellular biology.

[22]  Irving S. Sigal,et al.  Cloning of bovine GAP and its interaction with oncogenic ras p21 , 1988, Nature.

[23]  G. Cooper,et al.  Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP , 1988, Molecular and cellular biology.

[24]  S. Aaronson,et al.  Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene , 1987, Nature.

[25]  F. McCormick,et al.  A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. , 1987, Science.

[26]  B. Wasylyk,et al.  The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer , 1987, Cell.

[27]  A. Wolfman,et al.  Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts , 1987, Nature.

[28]  T. Curran,et al.  Microinjection of transforming ras protein induces c-fos expression , 1987, Molecular and cellular biology.

[29]  D. Lowy,et al.  Mutational analysis of a ras catalytic domain , 1986, Molecular and cellular biology.

[30]  D. Bar-Sagi,et al.  Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation , 1985, Cell.

[31]  E. Rozengurt,et al.  Synergistic Signals in Mitogenesis: Role of Ion Fluxes, Cyclic Nucleotides and Protein Kinase C in Swiss 3T3 Cells , 1985, Journal of Cell Science.

[32]  H. Kung,et al.  Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein , 1984, Nature.

[33]  R. Weinberg,et al.  Cellular oncogenes and multistep carcinogenesis. , 1983, Science.

[34]  J. Parsons.  Closing the GAP in a signal transduction pathway. , 1990, Trends in genetics : TIG.

[35]  A. Lloyd,et al.  Scrape-loading of Swiss 3T3 cells with ras protein rapidly activates protein kinase C in the absence of phosphoinositide hydrolysis. , 1989, Oncogene.

[36]  P. Herrlich,et al.  'Nuclear' oncogenes convert extracellular stimuli into changes in the genetic program. , 1989, Trends in genetics : TIG.

[37]  C. Yu,et al.  Critical role of cellular ras proteins in proliferative signal transduction. , 1988, Cold Spring Harbor symposia on quantitative biology.